Real-time Quote. Real-time  - 06/23 11:39:53 am
87.12EUR -0.70%

Sanofi : A trend reversal can be anticipated

11/19/2020 | 10:32am
Jordan Dufee
Senior Analyst

Strategy published on : 11/19/2020 | 10:32

long trade under condition
Conditional Order Terminated

Entry price : 87.5€
Target : 94€
Stop-loss : 83.5€
Cancellation Level : 83€
Potential : 7.43%

Sanofi reflects attractive technical aspects that could allow investors to expect a trend reversal over the medium term.
Investors should benefit from the breakout of the € 87.5 level to target the € 94.


● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.


● The company returns high margins, thereby supporting business profitability.

● Its low valuation, with P/E ratio at 9.24 and 18.11 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

© 2021
Copier lien
All news about SANOFI
1d ago
1d ago
1d ago
1d ago
1d ago